Medical Weight Loss for Lancaster, Pennsylvania Residents

Lancaster, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Lancaster through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in Pennsylvania: patients in Lancaster see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Lancaster Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Lancaster a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Pennsylvania. That is the entire promise, and we keep it.

Medical weight loss for Lancaster is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Living in Lancaster, Pennsylvania means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout the greater Lancaster area and Lancaster County, with bilingual Spanish care. A licensed care coordinator stays reachable by message and phone, so help is a few taps away anywhere in Pennsylvania.

Wherever you are in Lancaster or the wider Pennsylvania area, the program reaches you the same way, with HSA, FSA, Klarna, and Affirm all accepted. If you would rather spread payments out, Lancaster patients can use Klarna or Affirm at checkout instead of paying the full cost at once. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Lancaster choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Lancaster

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Lancaster and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Lancaster door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Lancaster

How does someone in Lancaster access New Hope Weight Loss?

Access from Lancaster is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Lancaster, Pennsylvania through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Lancaster residents?

A clinic visit is never part of it for Lancaster. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Lancaster inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Lancaster patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Lancaster residents are charged no distance surcharge.

What areas of Lancaster do you serve?

We serve patients from across Lancaster by telehealth, including the greater Lancaster area and Lancaster County, with bilingual Spanish care.

What does treatment cost for Lancaster patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Lancaster.

Lancaster Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lancaster, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.